111 related articles for article (PubMed ID: 12505289)
1. Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer.
Sweeney C; Coles BF; Nowell S; Lang NP; Kadlubar FF
Toxicology; 2002 Dec; 181-182():83-7. PubMed ID: 12505289
[TBL] [Abstract][Full Text] [Related]
2. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk.
Nowell S; Coles B; Sinha R; MacLeod S; Luke Ratnasinghe D; Stotts C; Kadlubar FF; Ambrosone CB; Lang NP
Mutat Res; 2002 Sep; 506-507():175-85. PubMed ID: 12351157
[TBL] [Abstract][Full Text] [Related]
3. CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.
Nowell S; Sweeney C; Hammons G; Kadlubar FF; Lang NP
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):377-83. PubMed ID: 11927498
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2A6 Phenotyping Using Dietary Caffeine Salivary Metabolite Ratios and Genotyping Using Blood on Storage Cards in Non-smoking Japanese Volunteers.
Murayama N; Shimizu M; Kobayashi K; Kishimoto I; Yamazaki H
Drug Metab Lett; 2017; 10(4):240-243. PubMed ID: 27842485
[TBL] [Abstract][Full Text] [Related]
5. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2A6 phenotyping based on dietary caffeine intake in a Japanese population of non-smokers.
Kimura M; Shimizu M; Kiyotani K; Nakagawa K; Kamataki T; Yamazaki H
Drug Metab Lett; 2012 Jun; 6(2):67-72. PubMed ID: 22849705
[TBL] [Abstract][Full Text] [Related]
7. Processed meat intake, CYP2A6 activity and risk of colorectal adenoma.
Ward MH; Cross AJ; Divan H; Kulldorff M; Nowell-Kadlubar S; Kadlubar FF; Sinha R
Carcinogenesis; 2007 Jun; 28(6):1210-6. PubMed ID: 17277235
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic CYP2A6 variation and the risk of pancreatic cancer.
Kadlubar S; Anderson JP; Sweeney C; Gross MD; Lang NP; Kadlubar FF; Anderson KE
JOP; 2009 May; 10(3):263-70. PubMed ID: 19454817
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
Begas E; Kouvaras E; Tsakalof A; Papakosta S; Asprodini EK
Biomed Chromatogr; 2007 Feb; 21(2):190-200. PubMed ID: 17221922
[TBL] [Abstract][Full Text] [Related]
10. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
11. Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans.
Kimura M; Yamazaki H; Fujieda M; Kiyotani K; Honda G; Saruwatari J; Nakagawa K; Ishizaki T; Kamataki T
Drug Metab Dispos; 2005 Sep; 33(9):1361-6. PubMed ID: 15980104
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the severity of alcoholic liver cirrhosis and the metabolism of caffeine in 226 patients.
Bechtel YC; Haffen E; Lelouët H; Brientini MP; Paintaud G; Miguet JP; Bechtel PR
Int J Clin Pharmacol Ther; 2000 Oct; 38(10):467-75. PubMed ID: 11073287
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the activity of cytochrome P-450 CYP2A6 by HPLC method with caffeine as metabolizing probe].
Li J; Peng XQ; Zhang J; Xu JP
Yao Xue Xue Bao; 2006 Mar; 41(3):282-4. PubMed ID: 16759004
[TBL] [Abstract][Full Text] [Related]
14. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
Cotterchio M; Boucher BA; Manno M; Gallinger S; Okey AB; Harper PA
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3098-107. PubMed ID: 18990750
[TBL] [Abstract][Full Text] [Related]
15. Caffeine metabolism before and after liver transplantation.
Bechtel YC; Lelouët H; Hrusovsky S; Brientini MP; Mantion G; Paintaud G; Miguet JP; Bechtel PR
Int J Clin Pharmacol Ther; 2001 Feb; 39(2):53-60. PubMed ID: 11270802
[TBL] [Abstract][Full Text] [Related]
16. High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.
Aklillu E; Djordjevic N; Carrillo JA; Makonnen E; Bertilsson L; Ingelman-Sundberg M
OMICS; 2014 Jul; 18(7):446-53. PubMed ID: 24380444
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children.
Sinués B; Fanlo A; Vicente J; Mayayo-Sinués E; Mayayo E; Labarta JI; Ferrandez-Longás A
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):45-9. PubMed ID: 17927692
[TBL] [Abstract][Full Text] [Related]
19. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.
Pitarque M; von Richter O; Rodríguez-Antona C; Wang J; Oscarson M; Ingelman-Sundberg M
Hum Mutat; 2004 Mar; 23(3):258-66. PubMed ID: 14974084
[TBL] [Abstract][Full Text] [Related]
20. [How I was enticed into molecular toxicology].
Kamataki T
Yakugaku Zasshi; 2006 Dec; 126(12):1309-18. PubMed ID: 17139156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
